IP Library Granted Patent US 8,603,070
Granted Patent B1
US 8,603,070 · App. 13/950,592 · Granted Dec 10, 2013

Catheters with high-purity fluoropolymer additives

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,603,070
App. No.
13/950,592
Granted
Dec 10, 2013
Kind
B1
Abstract

The present invention provides catheter compositions that provide anti-thrombogenic properties while not adversely impacting mechanical properties. All embodiments of the present invention comprise a catheter that comprises a fluoropolymer additive with specific compositions and/or purity levels.

Claims (26)

1. A catheter comprising:

an elongated tubular structure comprising a first polymer comprising polyurethane and a second polymer comprising polyfluoro-oligomeric groups;

wherein said second polymer is characterized by a polystyrene equivalent weight average molecular weight (M w ) greater than 13 kDa.

2. The catheter of claim 1 , wherein said second polymer has a polydispersity index of between 1.0 and 2.0.

3. The catheter of claim 2 , wherein said second polymer has a polydispersity index of between 1.0 and 1.5.

4. The catheter of claim 1 , wherein said second polymer is characterized by a polystyrene equivalent weight average molecular weight (M w ) within the range of 14 kDa to 26 kDa.

5. The catheter of claim 1 , wherein said polyurethane comprises a polycarbonate-based polyurethane.

6. The catheter of claim 1 , wherein said elongated tubular structure further comprises a radiopaque material.

7. The catheter of claim 6 , wherein said elongated tubular structure comprises about 25 weight percent to about 35 weight percent of said radiopaque material.

8. The catheter of claim 7 , wherein said elongated tubular structure comprises about 1.5 weight percent to about 2.5 weight percent of said second polymer.

9. The catheter of claim 6 , wherein said radiopaque material comprises barium sulfate.

10. The catheter of claim 9 , wherein said elongated tubular structure comprises up to about 30 weight percent of said barium sulfate.

11. The catheter of claim 1 , wherein said elongated tubular structure comprises an outer surface, at least one lumen, and a wall thickness between said outer surface and said at least one lumen, said wall thickness being at least 0.005 inches.

12. The catheter of claim 1 , wherein said elongated tubular structure comprises an outer surface, at least two lumens, and a wall thickness between said outer surface and any of said at least two lumens, said wall thickness being at least 0.005 inches.

13. The catheter of claim 1 , wherein said elongated tubular structure comprises an outer surface, at least three lumens, and a wall thickness between said outer surface and any of said at least three lumens, said wall thickness being at least 0.005 inches.

14. A catheter comprising:

an elongated tubular structure comprising a polymeric material comprising:

a first polymer comprising polyurethane; and

additives comprising a second polymer comprising polyfluoro-oligomeric groups;

wherein said second polymer is characterized by a polystyrene equivalent weight average molecular weight (M w ) greater than 13 kDa and a polydispersity index of between 1.0 and 2.0.

15. The catheter of claim 14 , wherein said polymeric material comprises up to about 44 weight percent of said additives.

16. The catheter of claim 14 , wherein said polymeric material comprises up to about 40 weight percent of said additives.

17. The catheter of claim 14 , wherein said polymeric material comprises up to about 33 weight percent of said additives.

18. The catheter of claim 14 , wherein said polymeric material comprises about 25 weight percent to about 35 weight percent of a radiopaque material.

19. The catheter of claim 18 , wherein said polymeric material comprises about 1.5 weight percent to about 2.5 weight percent of said second polymer.

20. The catheter of claim 19 , wherein said polymeric material comprises up to about 0.2 weight percent of a colorant.

Assignments (8)
RELEASE OF SECURITY INTEREST Recorded Jun 8, 2023
From: JPMORGAN CHASE BANK, N.A., AS ADMINISTRATIVE AGENT
To: ANGIODYNAMICS, INC.
Reel/Frame 063940/0362 →
SECURITY INTEREST Recorded Aug 31, 2022
From: ANGIODYNAMICS, INC.
To: JPMORGAN CHASE BANK, N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 061360/0668 →
RELEASE OF SECURITY INTEREST Recorded Aug 31, 2022
From: JPMORGAN CHASE BANK, N.A., AS ADMINISTRATIVE AGENT
To: ANGIODYNAMICS, INC.
Reel/Frame 061363/0446 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 10, 2019
From: INTERFACE BIOLOGICS, INC.
To: EVONIK CANADA INC.
Reel/Frame 050681/0944 →
CONFIRMATORY GRANT OF SECURITY INTEREST IN UNITED STATES PATENTS Recorded Jun 5, 2019
From: ANGIODYNAMICS, INC.
To: JPMORGAN CHASE BANK, N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 049371/0657 →
SECURITY INTEREST Recorded Nov 8, 2016
From: ANGIODYNAMICS, INC.
To: JPMORGAN CHASE BANK, N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 040613/0049 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 3, 2014
From: SANTERRE, J. PAUL; HO, JEANNETTE
To: INTERFACE BIOLOGICS INC.
Reel/Frame 032596/0910 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 29, 2013
From: LAREAU, RAYMOND; BELL, BENJAMIN
To: ANGIODYNAMICS, INC.
Reel/Frame 030892/0293 →